Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Jazz Pharmaceuticals (JAZZ) has issued an update.
Catherine Sohn, Pharm.D. has informed Jazz Pharmaceuticals that she will retire and not seek re-election to the company’s board at the upcoming 2024 annual meeting. Her departure is amicable, with no disputes or disagreements with the company’s operations, policies, or practices mentioned as a reason for her retirement.
Find detailed analytics on JAZZ stock on TipRanks’ Stock Analysis page.
